📰 Haemonetics Daily News
Haemonetics Daily News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Haemonetics Daily. Real-time updates on events, politics, business and more.
June 2, 2024
Eagle Asset Management Inc. raised its position in Haemonetics Co. (NYSE:HAE – Free Report) by 1.4% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 272,526 shares of the medical instruments supplier’s stock after purchasing an additional 3,883 shares during the period. Eagle Asset Management Inc. owned […]
June 1, 2024
Qtron Investments LLC increased its position in shares of Haemonetics Co. (NYSE:HAE – Free Report) by 5.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 6,310 shares of the medical instruments supplier’s stock after acquiring an additional 343 shares during the quarter. Qtron […]
May 30, 2024
Haemonetics (NYSE:HAE – Get Free Report) and Coloplast A/S (OTCMKTS:CLPBF – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, valuation, earnings and profitability. Analyst Ratings This is a breakdown of recent ratings […]
May 20, 2024
Haemonetics (NYSE:HAE – Get Free Report) and PAVmed (NASDAQ:PAVM – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability. Profitability This table compares Haemonetics and PAVmed’s net margins, return […]
May 18, 2024
Jump Financial LLC acquired a new position in shares of Haemonetics Co. (NYSE:HAE – Free Report) in the 4th quarter, Holdings Channel.com reports. The fund acquired 12,066 shares of the medical instruments supplier’s stock, valued at approximately $1,032,000. A number of other hedge funds have also bought and sold shares of HAE. Group One Trading […]
April 10, 2024
Peregrine Capital Management LLC trimmed its stake in shares of Haemonetics Co. (NYSE:HAE – Free Report) by 14.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 110,313 shares of the medical instruments supplier’s stock after selling 18,094 shares during […]
April 10, 2024
Peregrine Capital Management LLC lowered its stake in shares of Haemonetics Co. (NYSE:HAE – Free Report) by 14.1% in the fourth quarter, Holdings Channel.com reports. The firm owned 110,313 shares of the medical instruments supplier’s stock after selling 18,094 shares during the period. Peregrine Capital Management LLC’s holdings in Haemonetics were worth $9,433,000 as of […]
March 29, 2024
Haemonetics Co. (NYSE:HAE – Free Report) – Zacks Research lifted their Q1 2025 EPS estimates for shares of Haemonetics in a report issued on Thursday, March 28th. Zacks Research analyst R. Department now expects that the medical instruments supplier will post earnings of $0.94 per share for the quarter, up from their prior estimate of […]
February 11, 2024
Haemonetics (NYSE:HAE – Get Free Report) issued its quarterly earnings data on Thursday. The medical instruments supplier reported $1.04 EPS for the quarter, beating the consensus estimate of $0.94 by $0.10, Briefing.com reports. Haemonetics had a return on equity of 22.37% and a net margin of 9.97%. The company had revenue of $336.20 million for […]
February 10, 2024
Haemonetics Co. (NYSE:HAE – Get Free Report) gapped up prior to trading on Thursday after the company announced better than expected quarterly earnings. The stock had previously closed at $77.11, but opened at $81.26. Haemonetics shares last traded at $78.45, with a volume of 398,865 shares. The medical instruments supplier reported $1.04 EPS for the […]